Castle Biosciences Inc
NASDAQ:CSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
S
|
Star Diamond Corp
XBER:GOC
|
CA |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
A
|
Azimut Holding SpA
XBER:HDB
|
IT |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
Apollo Micro Systems Ltd
NSE:APOLLO
|
IN |
|
G
|
Global Payments Inc
F:GLO
|
US |
|
H
|
Headwater Exploration Inc
XMUN:C6V
|
CA |
|
Siemens Healthineers AG
OTC:SMMNY
|
DE |
|
F
|
Fifth Third Bancorp
F:FFH
|
US |
|
B
|
BlackBerry Ltd
XMUN:RI1
|
CA |
|
A
|
ANTA Sports Products Ltd
XBER:AS7
|
CN |
|
W
|
Wheaton Precious Metals Corp
LSE:WPM
|
CA |
|
E
|
Evolution AB (publ)
F:E3G
|
SE |
|
F
|
Fuji Media Holdings Inc
XBER:FTN
|
JP |
|
Siegfried Holding AG
F:SQG
|
CH |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
|
M
|
Markel Corp
F:MKV
|
US |
|
I
|
Indika Energy Tbk PT
XBER:I41
|
ID |
|
Kennedy-Wilson Holdings Inc
NYSE:KW
|
US |
|
A
|
Atoss Software AG
XMUN:AOF
|
DE |
|
Atoss Software AG
LSE:0N66
|
DE |
|
B
|
Bayerische Motoren Werke AG
XBER:BMW
|
DE |
|
Bayan Resources Tbk PT
F:BNB
|
ID |
Wall St Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for CSTL is 44.43 USD with a low forecast of 35.35 USD and a high forecast of 54.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CSTL's stock price target?
Price Target
44.43
USD
According to Wall Street analysts, the average 1-year price target for CSTL is 44.43 USD with a low forecast of 35.35 USD and a high forecast of 54.6 USD.
What is the Revenue forecast for Castle Biosciences Inc?
Projected CAGR
9%
Over the last 7 years, the compound annual growth rate for Revenue has been 47%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Castle Biosciences Inc?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 3 years is 7%.
